122 related articles for article (PubMed ID: 38271117)
1. Comprehensive assessment of immune context and immunotherapy response via noninvasive imaging in gastric cancer.
Sun Z; Zhang T; Ahmad MU; Zhou Z; Qiu L; Zhou K; Xiong W; Xie J; Zhang Z; Chen C; Yuan Q; Chen Y; Feng W; Xu Y; Yu L; Wang W; Yu J; Li G; Jiang Y
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38271117
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer.
Huang W; Jiang Y; Xiong W; Sun Z; Chen C; Yuan Q; Zhou K; Han Z; Feng H; Chen H; Liang X; Yu S; Hu Y; Yu J; Chen Y; Zhao L; Liu H; Zhou Z; Wang W; Wang W; Xu Y; Li G
Nat Commun; 2022 Aug; 13(1):5095. PubMed ID: 36042205
[TBL] [Abstract][Full Text] [Related]
3. A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study.
Zhan PC; Yang S; Liu X; Zhang YY; Wang R; Wang JX; Qiu QY; Gao Y; Lv DB; Li LM; Luo CL; Hu ZW; Li Z; Lyu PJ; Liang P; Gao JB
BMC Cancer; 2024 Apr; 24(1):404. PubMed ID: 38561648
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study.
Huang W; Xiong W; Tang L; Chen C; Yuan Q; Zhang C; Zhou K; Sun Z; Zhang T; Han Z; Feng H; Liang X; Zhong Y; Deng H; Yu L; Xu Y; Wang W; Shen L; Li G; Jiang Y
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38179695
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive measurement of tumor immune microenvironment and prediction of survival and chemotherapeutic benefits from
Li J; Zhang C; Guo H; Li S; You Y; Zheng P; Zhang H; Wang H; Bai J
Front Immunol; 2022; 13():1019386. PubMed ID: 36311742
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer.
Jiang Y; Wang H; Wu J; Chen C; Yuan Q; Huang W; Li T; Xi S; Hu Y; Zhou Z; Xu Y; Li G; Li R
Ann Oncol; 2020 Jun; 31(6):760-768. PubMed ID: 32240794
[TBL] [Abstract][Full Text] [Related]
7. Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Han X; Guo Y; Ye H; Chen Z; Hu Q; Wei X; Liu Z; Liang C
Breast Cancer Res; 2024 Jan; 26(1):18. PubMed ID: 38287356
[TBL] [Abstract][Full Text] [Related]
8. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics.
Jiang Y; Zhou K; Sun Z; Wang H; Xie J; Zhang T; Sang S; Islam MT; Wang JY; Chen C; Yuan Q; Xi S; Li T; Xu Y; Xiong W; Wang W; Li G; Li R
Cell Rep Med; 2023 Aug; 4(8):101146. PubMed ID: 37557177
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
[TBL] [Abstract][Full Text] [Related]
11. Development and external validation of a non-invasive imaging biomarker to estimate the microsatellite instability status of gastric cancer and its prognostic value: The combination of clinical and quantitative CT-imaging features.
Zhao H; Gao J; Bai B; Wang R; Yu J; Lu H; Cheng M; Liang P
Eur J Radiol; 2023 May; 162():110719. PubMed ID: 36764010
[TBL] [Abstract][Full Text] [Related]
12. Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer.
Li Y; Li X; Yang Y; Qiao X; Tao Q; Peng C; Han M; Dong K; Xu M; Wang D; Han G
Front Immunol; 2023; 14():1289700. PubMed ID: 38022516
[TBL] [Abstract][Full Text] [Related]
13. Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells.
Sun R; Sundahl N; Hecht M; Putz F; Lancia A; Rouyar A; Milic M; Carré A; Battistella E; Alvarez Andres E; Niyoteka S; Romano E; Louvel G; Durand-Labrunie J; Bockel S; Bahleda R; Robert C; Boutros C; Vakalopoulou M; Paragios N; Frey B; Soria JC; Massard C; Ferté C; Fietkau R; Ost P; Gaipl U; Deutsch E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188037
[TBL] [Abstract][Full Text] [Related]
14. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
[TBL] [Abstract][Full Text] [Related]
15. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive evaluation of neutrophil extracellular traps signature predicts clinical outcomes and immunotherapy response in hepatocellular carcinoma.
Xin H; Lai Q; Zhou Y; He J; Song Y; Liao M; Sun J; Li M; Zhang M; Liang W; Bai Y; Zhang Y; Zhou Y
Front Immunol; 2023; 14():1134521. PubMed ID: 37520528
[TBL] [Abstract][Full Text] [Related]
17. Prognostic aspects of lymphovascular invasion in localized gastric cancer: new insights into the radiomics and deep transfer learning from contrast-enhanced CT imaging.
Li Q; Feng QX; Qi L; Liu C; Zhang J; Yang G; Zhang YD; Liu XS
Abdom Radiol (NY); 2022 Feb; 47(2):496-507. PubMed ID: 34766197
[TBL] [Abstract][Full Text] [Related]
18. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
[TBL] [Abstract][Full Text] [Related]
19. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
20. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
